-
Something wrong with this record ?
Characterization of ferritin 2 for the control of tick infestations
O. Hajdušek, C. Almazán, G. Loosová, M. Villar, M. Canales, L. Grubhoffer, P. Kopáček, J. de la Fuente
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 2002-01-01 to 2 months ago
Nursing & Allied Health Database (ProQuest)
from 2002-01-01 to 2 months ago
Health & Medicine (ProQuest)
from 2002-01-01 to 2 months ago
Family Health Database (ProQuest)
from 2002-01-01 to 2 months ago
Health Management Database (ProQuest)
from 2002-01-01 to 2 months ago
Public Health Database (ProQuest)
from 2002-01-01 to 2 months ago
- MeSH
- Escherichia coli genetics MeSH
- Ferritins antagonists & inhibitors immunology isolation & purification MeSH
- Insect Proteins antagonists & inhibitors immunology isolation & purification MeSH
- Tick Infestations prevention & control veterinary MeSH
- Ixodes immunology MeSH
- Rabbits parasitology MeSH
- Cattle Diseases parasitology prevention & control MeSH
- Rhipicephalus immunology MeSH
- Cattle MeSH
- Vaccines, Synthetic immunology MeSH
- Animals MeSH
- Check Tag
- Rabbits parasitology MeSH
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Ixodes ricinus is one the most abundant tick species in Europe and these ticks transmit pathogens causing human and animal diseases. The cattle ticks, Rhipicephalus (Boophilus) spp., affect cattle production in tropical and subtropical regions of the world. Development of vaccines directed against tick proteins may reduce tick infestations and the transmission of tick-borne pathogens. However, a limiting step in tick vaccine development has been the identification of tick protective antigens. Herein, the tick iron metabolism pathway was targeted in an effort to identify new tick protective antigens. Recombinant I. ricinus (IrFER2) and Rhipicephalus microplus (RmFER2) ferritin 2 proteins were expressed in Escherichia coli and used to immunize rabbits and cattle, respectively. Vaccination with IrFER2 reduced I. ricinus tick numbers, weight and fertility in rabbits with an overall vaccine efficacy (E) of 98%. Control of cattle tick, R. microplus and Rhipicephalus annulatus infestations was obtained in vaccinated cattle with overall E of 64% and 72%, respectively. Notably, the efficacy of the RmFER2 vaccine was similar to that obtained with Bm86 against R. microplus. These collective results demonstrated the feasibility of using ferritin 2 to develop vaccines for the control of tick infestations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025170
- 003
- CZ-PrNML
- 005
- 20221005161718.0
- 007
- ta
- 008
- 120816s2010 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.vaccine.2010.02.008 $2 doi
- 035 __
- $a (PubMed)20171306
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Hajdušek, Ondřej $7 stk2009493272 $u Institute of Parasitology, Biology Centre, Academy of Sciences of the Czech Republic, Branisovska 31, 37005 Ceske Budejovice, Czech Republic.
- 245 10
- $a Characterization of ferritin 2 for the control of tick infestations / $c O. Hajdušek, C. Almazán, G. Loosová, M. Villar, M. Canales, L. Grubhoffer, P. Kopáček, J. de la Fuente
- 520 9_
- $a Ixodes ricinus is one the most abundant tick species in Europe and these ticks transmit pathogens causing human and animal diseases. The cattle ticks, Rhipicephalus (Boophilus) spp., affect cattle production in tropical and subtropical regions of the world. Development of vaccines directed against tick proteins may reduce tick infestations and the transmission of tick-borne pathogens. However, a limiting step in tick vaccine development has been the identification of tick protective antigens. Herein, the tick iron metabolism pathway was targeted in an effort to identify new tick protective antigens. Recombinant I. ricinus (IrFER2) and Rhipicephalus microplus (RmFER2) ferritin 2 proteins were expressed in Escherichia coli and used to immunize rabbits and cattle, respectively. Vaccination with IrFER2 reduced I. ricinus tick numbers, weight and fertility in rabbits with an overall vaccine efficacy (E) of 98%. Control of cattle tick, R. microplus and Rhipicephalus annulatus infestations was obtained in vaccinated cattle with overall E of 64% and 72%, respectively. Notably, the efficacy of the RmFER2 vaccine was similar to that obtained with Bm86 against R. microplus. These collective results demonstrated the feasibility of using ferritin 2 to develop vaccines for the control of tick infestations.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a nemoci skotu $x parazitologie $x prevence a kontrola $7 D002418
- 650 _2
- $a Escherichia coli $x genetika $7 D004926
- 650 _2
- $a ferritiny $x antagonisté a inhibitory $x imunologie $x izolace a purifikace $7 D005293
- 650 _2
- $a hmyzí proteiny $x antagonisté a inhibitory $x imunologie $x izolace a purifikace $7 D019476
- 650 _2
- $a klíště $x imunologie $7 D018884
- 650 _2
- $a králíci $x parazitologie $7 D011817
- 650 _2
- $a Rhipicephalus $x imunologie $7 D048494
- 650 _2
- $a infestace klíšťaty $x prevence a kontrola $x veterinární $7 D013984
- 650 _2
- $a syntetické vakcíny $x imunologie $7 D014614
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Almazán, Consuelo $7 gn_A_00004609
- 700 1#
- $a Loosová, Gabriela. $7 _AN070811
- 700 1_
- $a Villar, Margarita
- 700 1_
- $a Canales, Mario
- 700 1_
- $a Grubhoffer, Libor, $d 1957- $7 xx0021786
- 700 1#
- $a Kopáček, Petr, $d 1958- $7 _AN030739
- 700 1_
- $a de la Fuente, José
- 773 0_
- $w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 28, č. 17 (2010), s. 2993-2998
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20221005161714 $b ABA008
- 999 __
- $a ok $b bmc $g 947212 $s 782516
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 28 $c 17 $d 2993-2998 $e 20100218 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
- LZP __
- $a Pubmed-20120816/10/02